Alpine Immune Sciences Commences Underwritten Public Offering Of $150M Of Shares Of Its Common Stock
Portfolio Pulse from Benzinga Newsdesk
Alpine Immune Sciences has started an underwritten public offering of $150M of its common stock. The underwriters are expected to be granted an option to purchase up to an additional $22.5M of shares at the public offering price, less the underwriting discounts and commissions.
November 06, 2023 | 11:01 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Alpine Immune Sciences' public offering could increase the number of shares in circulation, potentially diluting the value of existing shares.
The public offering will increase the number of shares in circulation. This could dilute the value of existing shares, potentially leading to a decrease in the stock price. The underwriters' option to purchase additional shares could further increase this effect.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100